loader2
Login Open ICICI 3-in-1 Account

Yatharth Hospital & Trauma Care Services Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Yatharth Hospital & Trauma Care Services Ltd. 13 Nov 2025 14:59 PM

Q2FY26 Quarterly Result Announced for Yatharth Hospital & Trauma Care Services Ltd.

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q2FY26 results

  • Operating Revenue at record Rs 2,794 million during the quarter, up 28% YoY.
  • EBITDA stood at a record Rs 645 million, up 18% YoY.
  • PAT at Rs 413 million, up by 33% YoY.
  • Net Cash Position as on Sep-25 stood at Rs 3,692 million.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are delighted to report another quarter of record revenues and EBITDA, driven by strong growth from our existing hospitals and the successful ramp-up of our new facilities. During the quarter, we operationalised our Model Town, Delhi and Faridabad hospitals, adding 700 beds, and acquired Shantived Hospital in Agra, adding ~250 beds. These milestones keep us ahead of schedule in achieving our bed expansion target.

We also strengthened governance by appointing MSKA & Associates (BDO International member firm) as our statutory auditor for Q2 financials and welcoming healthcare veteran Mr. Ramesh Krishnan as an independent director. Additionally, the Income Tax authorities have released provisional attachments of all properties and fixed deposits of the Company. We continue to prioritize strategic initiatives that deliver strong, sustainable growth and long-term stakeholder value.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q1FY26 results

  • Operating Revenue at Rs 2,578 million, up 22% YoY and 11% QoQ.
  • EBITDA at Rs 645 million, up 20% YoY and 13% QoQ, reflecting 13 consecutive quarters of EBITDA growth.
  • EBITDA margin improved 41 bps QoQ to 25.0%.
  • PAT at Rs 425 million, up by 40% YoY, despite higher depreciation led by capacity expansion.
  • Bed Occupancy increased to 65%, from 61% in Q1FY25.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are happy to report yet another quarter of consistent and robust growth at Yatharth Hospitals, marked by strong revenue performance and profitability growth in Q1FY26. This reflects our unwavering focus on operational excellence and disciplined expansion. With the Model Town and the Faridabad facility, having a combined capacity of 700 beds, we expect to further accelerate our growth momentum from Q2FY26 onwards. During the quarter, we successfully resolved the Jhansi-Orchha land issue, removing a key operational hurdle and paving the way for future development. We remain confident that these strategic initiatives will enable Yatharth Hospitals to sustain its growth trajectory and continue delivering long-term value to all stakeholders.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Operating Revenue at Rs 2,318 million, up 30% YoY
  • Bed occupancy at 61%, compared to 57% in Q4 FY24
  • ARPOB at Rs 31,441, up 7% YoY
    • Noida Extension registers highest ARPOB at Rs 38.8k ( 11% YoY), followed by Greater Noida at Rs 35k ( 16% YoY)
  • EBITDA at Rs 570 million, up 23% YoY; EBITDA margin at 24.6%
  • PBT at Rs 485 million, up 10% YoY and 21% QoQ
  • PAT at Rs 387 million, up 1% YoY and 27% QoQ, due to lower taxes in the base year
  • Received possession of two upcoming hospitals – a 300 bed facility in Delhi and a ~400 bed facility in Faridabad – both of which are expected to become operational in Q1 FY26

FY25 Financial Highlights:

  • Operating Revenue at Rs 8,805 million, up 31% YoY
  • Bed occupancy at 61%, compared to 54% in FY24
    • Noida Extension and Jhansi-Orchha occupancy improves significantly to ~60% & 50% respectively in FY25, compared to 44% & 23% in FY24
  • ARPOB at Rs 30,829, up 8% YoY
    • Noida Extension ARPOB at Rs 38k, marking a 12% increase over FY24, while Greater Noida recorded an ARPOB of Rs 34.6k, reflecting a robust 20% YoY growth. These improvements reflect the effectiveness of the strategic focus on super-specialty services.
    • Faridabad achieves an ARPOB of Rs 31k
  • EBITDA at Rs 2,202 million, up 22% YoY; EBITDA margin at 25.0%, compared to 26.8% in the previous year, due to initial ramp-up costs associated with the newly operationalized Greater Faridabad facility
  • Depreciation increased to Rs 572 million, reflecting the expansion of our bed capacity and investment in advanced medical equipment across key hospitals
  • PAT at Rs 1,306 million, up 14% YoY; PAT margin at 14.8%
  • Net Cash position as on Mar-25 stood at Rs 5,032 million

Commenting on the performance, Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are pleased to report another quarter and year of robust growth at Yatharth Hospitals. Notably, our Operating Cash Flows were healthy at Rs 1,496 million in FY2025, with a cash conversion ratio of 68%, reflecting healthy profit to cash flows conversion. During the quarter, we received possession of our two newly acquired hospitals in New Delhi and Faridabad, adding approximately 300 and 400 beds, respectively, which are getting operationalise in Q1FY26. Looking ahead, we remain confident in our ability to sustain our growth trajectory, supported by significant investments in bed capacity expansion and advanced medical infrastructure.”

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app